<DOC>
	<DOCNO>NCT02776982</DOCNO>
	<brief_summary>This study do help understand people increased amount central obesity , without gastroesophageal reflux , develop change line esophagus potentially lead esophageal adenocarcinoma ( cancer ) .</brief_summary>
	<brief_title>Influence Central Obesity Esophageal Epithelial Barrier</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<criteria>Participants undergo clinically indicate 24hour ambulatory impedance pH monitoring ( reflux medication 7 day ) , Esophageal Function Laboratory Mayo Clinic , follow endoscopy within 2496 hour . 1 . Preexisting suspect Barrett 's Esophagus ( &gt; 1cm columnar mucosa esophagus endoscopy 2 . Oral anticoagulation preclude endoscopic biopsy 3 . Patients know hypersensitivity fluorescein sodium .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Barrett 's Esophagus</keyword>
	<keyword>Esophageal adenocarcinoma</keyword>
</DOC>